Skip to main content

Peer Review reports

From: Potentiation of in vitro and in vivoantitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells

Original Submission
13 Sep 2012 Submitted Original manuscript
17 Dec 2012 Author responded Author comments - kalpana joshi
Resubmission - Version 2
17 Dec 2012 Submitted Manuscript version 2
16 Jan 2013 Editorially accepted
23 Jan 2013 Article published 10.1186/1471-2407-13-29

You can find further information about peer review here.

Back to article page